Literature DB >> 18252255

Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels.

Laura Sanz1, Patricia Santos-Valle, Vanesa Alonso-Camino, Clara Salas, Antonio Serrano, José Luís Vicario, Angel M Cuesta, Marta Compte, David Sánchez-Martín, Luís Alvarez-Vallina.   

Abstract

Angiogenesis is a multistep process that encompasses complex molecular and cellular interactions that can not be recapitulated in vitro. Here, we demonstrate that vasculature generated from lentivirally transduced human primary endothelial cells expressing firefly luciferase and co-implanted with human bone marrow mesenchymal stem cells in immunodeficient mice can be assessed quantitatively by in vivo whole body bioluminescence imaging for more than 120 days. Luciferase activity correlated with the formation of a network of functional, mature blood vessels of human nature inside the implant that critically depend on the presence of mesenchymal stem cells. In summary, our study offers an unprecedented opportunity to perform long-term serial analysis of the molecular events involved in the angiogenic process and monitoring responses to anti-angiogenic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18252255     DOI: 10.1016/j.mvr.2007.11.007

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  30 in total

1.  Efficient in vivo vascularization of tissue-engineering scaffolds.

Authors:  Anja Hegen; Anna Blois; Crina E Tiron; Monica Hellesøy; David R Micklem; Jacques E Nör; Lars A Akslen; James B Lorens
Journal:  J Tissue Eng Regen Med       Date:  2010-09-23       Impact factor: 3.963

Review 2.  Advances in bioluminescence imaging of live animal models.

Authors:  Robin S Dothager; Kelly Flentie; Britney Moss; Mei-Hsiu Pan; Aparna Kesarwala; David Piwnica-Worms
Journal:  Curr Opin Biotechnol       Date:  2009-02-23       Impact factor: 9.740

3.  Adult mesenchymal stem cells and the NO pathways.

Authors:  Arnold I Caplan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-08       Impact factor: 11.205

4.  Fibronectin coating of collagen modules increases in vivo HUVEC survival and vessel formation in SCID mice.

Authors:  T P Cooper; M V Sefton
Journal:  Acta Biomater       Date:  2010-11-06       Impact factor: 8.947

5.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

Review 6.  In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury.

Authors:  Danilo C de Almeida; Cassiano Donizetti-Oliveira; Priscilla Barbosa-Costa; Clarice St Origassa; Niels Os Câmara
Journal:  Clin Biochem Rev       Date:  2013-11

Review 7.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

8.  Hypoxia impedes vasculogenesis of in vitro engineered bone.

Authors:  Debby Gawlitta; Joost O Fledderus; Mattie H P van Rijen; Inge Dokter; Jacqueline Alblas; Marianne C Verhaar; Wouter J A Dhert
Journal:  Tissue Eng Part A       Date:  2011-10-04       Impact factor: 3.845

9.  Sonic hedgehog promotes angiogenesis and osteogenesis in a coculture system consisting of primary osteoblasts and outgrowth endothelial cells.

Authors:  Eva Dohle; Sabine Fuchs; Marlen Kolbe; Alexander Hofmann; Harald Schmidt; Charles James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

10.  Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.

Authors:  Marta Compte; Angel M Cuesta; David Sánchez-Martín; Vanesa Alonso-Camino; José Luís Vicario; Laura Sanz; Luís Alvarez-Vallina
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.